• Featured Product
  • KD/KO验证

SFRS2 Polyclonal antibody

SFRS2 Polyclonal Antibody for WB, IHC, IF/ICC, IP, ELISA
Cat No. 20371-1-AP

产品说明书

宿主/亚型

Rabbit / IgG

种属反应性

human, mouse, rat

应用

WB, IHC, IF/ICC, IP, ELISA and More (2)

Serine/arginine-rich splicing factor 2, SC-35, SC35, SC 35, Protein PR264

缓冲液配方:  PBS and Azide
PBS and Azide
偶联物:  Unconjugated
Unconjugated
规格: 

-/ -


经过测试的应用

Positive WB detected inNIH/3T3 cells, mouse testis tissue, A549 cells, rat brain tissue, HepG2 cells
Positive IP detected inmouse brain tissue
Positive IHC detected inhuman lung cancer tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive IF/ICC detected inHepG2 cells
Planning an IHC experiment? We recommend our IHCeasy SFRS2 Ready-To-Use IHC Kit. SFRS2 primary antibody included.

推荐稀释比

应用推荐稀释比
Western Blot (WB)WB : 1:1000-1:8000
Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunohistochemistry (IHC)IHC : 1:50-1:500
Immunofluorescence (IF)/ICCIF/ICC : 1:1500-1:6000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

产品信息

20371-1-AP targets SFRS2 in WB, IHC, IF/ICC, IP, RIP, ELISA applications and shows reactivity with human, mouse, rat samples.

经测试应用 WB, IHC, IF/ICC, IP, ELISA Application Description
文献引用应用WB, IF, RIP
经测试反应性 human, mouse, rat
文献引用反应性human, mouse, rat
免疫原 Peptide 种属同源性预测
宿主/亚型 Rabbit / IgG
抗体类别 Polyclonal
产品类型 Antibody
全称 splicing factor, arginine/serine-rich 2
别名 Serine/arginine-rich splicing factor 2, SC-35, SC35, SC 35, Protein PR264
计算分子量 25 kDa
观测分子量 25-35 kDa
GenBank蛋白编号NM_003016
基因名称 SFRS2
Gene ID (NCBI) 6427
RRIDAB_2616311
偶联类型 Unconjugated
形式 Liquid
纯化方式Antigen affinity purification
UNIPROT IDQ01130
储存缓冲液 PBS with 0.02% sodium azide and 50% glycerol , pH 7.3
储存条件Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

背景介绍

SFRS2, also named as PR264 and Splicing component, 35 kDa, belongs to the splicing factor SR family. SFRS2 is necessary for the splicing of pre-mRNA. Some residue of SFRS2 is modified by phosphorylase and acetylase after translation. The molecular weight of modified SFRS2 is 35-40kDa. It is required for formation of the earliest ATP-dependent splicing complex and interacts with spliceosomal components bound to both the 5'- and 3'-splice sites during spliceosome assembly. It also is required for ATP-dependent interactions of both U1 and U2 snRNPs with pre-mRNA. It binds to purine-rich RNA sequences, either 5'-AGSAGAGTA-3' (S=C or G) or 5'-GTTCGAGTA-3'. SFRS2 can bind to beta-globin mRNA and commit it to the splicing pathway. The antibody has no cross reaction to SFRS2B.

实验方案

Product Specific Protocols
WB protocol for SFRS2 antibody 20371-1-APDownload protocol
IHC protocol for SFRS2 antibody 20371-1-APDownload protocol
IF protocol for SFRS2 antibody 20371-1-APDownload protocol
IP protocol for SFRS2 antibody 20371-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

发表文章

SpeciesApplicationTitle
humanWB

Nat Commun

Mutually exclusive acetylation and ubiquitylation of the splicing factor SRSF5 control tumor growth.

Authors - Yuhan Chen
humanWB

EMBO Mol Med

SRSF protein kinase 1 modulates RAN translation and suppresses CGG repeat toxicity

Authors - Indranil Malik
human,mouseWB

Am J Cancer Res

tRF-20-M0NK5Y93-induced MALAT1 promotes colon cancer metastasis through alternative splicing of SMC1A

Authors - Na Luan
  • KD Validated
humanIF

J Biol Chem

Proteomic study identifies Aurora-A mediated regulation of alternative splicing through multiple splicing factors

Authors - Arun Prasath Damodaran
humanWB

Neuroscience

The Age-dependent Elevation of miR-335-3p Leads to Reduced Cholesterol and Impaired Memory in Brain.

Authors - Obayed Raihan
mouseWB

Cell Rep

SFRS11 Loss Leads to Aging-Associated Cognitive Decline by Modulating LRP8 and ApoE.

Authors - Obayed Raihan
Loading...